LON:VEC - Vectura Group Share Price, Forecast & News

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

Vectura Group declared a dividend on Tuesday, September 10th. Investors of record on Monday, October 14th will be paid a dividend of GBX 6 per share on Friday, October 25th. The ex-dividend date is Monday, October 14th. The official announcement can be seen at this link. View Vectura Group's Dividend History.

Vectura Group is scheduled to release their next quarterly earnings announcement on Tuesday, March 17th 2020. View Earnings Estimates for Vectura Group.

6 brokerages have issued 1 year price objectives for Vectura Group's shares. Their forecasts range from GBX 114 to GBX 160. On average, they expect Vectura Group's stock price to reach GBX 138.50 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price. View Analyst Price Targets for Vectura Group.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Vectura Group.

Media headlines about VEC stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vectura Group earned a coverage optimism score of 0.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Vectura Group.

Some companies that are related to Vectura Group include Opthea (OPT), Medical Developments International (MVP), Mayne Pharma Group (MYX), BEXIMCO PHARMAC/S GDR REGS (BXP), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Recce Pharmaceuticals (RCE), NanoViricides (NNVC), Pharmaxis (PXS), Vita Life Sciences (VLS), Futura Medical (FUM), Avivagen (VIV), Patrys (PAB) and Antisense Therapeutics (ANP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SkyePharma (SKP), Barratt Developments (BDEV), BP (BP), BTG (BTG), Vesuvius (VSVS), Purplebricks Group (PURP), SINR PHAR/PAR VTG FPD 0.01 (SPH), iRobot (IRBT) and Sirius Minerals (SXX).

Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of VEC stock can currently be purchased for approximately GBX 92.80.

Vectura Group has a market capitalization of £564.52 million and generates £172.30 million in revenue each year. Vectura Group employs 478 workers across the globe.View Additional Information About Vectura Group.

The official website for Vectura Group is http://www.vectura.com/.

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company can be reached via phone at +44-1249-667700.